Value Research

Lesha Industries (BSE Code : 533602) A Ahmedabad And Mumbai Based couple of Punter operators are at it again. With a view to cheating the small investors, they have started a Bubble Making exercise to push up the stock price of Lesha Industries which is priced around Rs. 9. Propa- ganda has been started They Are Advice By Many Ways To Traders Or Investor to buy Lesha in sizeable quantities. Really speaking, the Gujarat based company engaged in trading and manufacturing of steel products is not doing well. Its performance is nothing worth writing home about. Last year (March 2015), its sales had declined from Rs. 26 crore in the fiscal 2014 to Rs. 7 crore and for the last several years it is incurring losses. On what basis these Tapori operators advise investors to buy these shares is known to them only.

Nitin Spinners: Spinning Story (BSE Code: 532698) (CMP: Rs.57) (FV: Rs.10) The share of Nitin Spinners Ltd (NSL) can be bought for decent gains is in the medium-to-long-term. The share has fallen from its 52-week high of Rs.107 and is now available at a 50% discount from the high. It has the potential to appreciate by 40%. NSL went through a turbulent phase after the 2008 global crisis due to substantial forex losses and resorted to corporate debt restructuring (CDR) in 2009. In early 2013, however, it was able to voluntarily exit from the CDR after paying a recompense amount to its lenders. NSL, a recognized ‘Export House’ was incorporated on 15 October 1992 as Nitin Spinners Pvt Ltd. In 1993, the Company set up its first unit at Hamirgarh in Bhilwara (Rajasthan) for manufacturing coarse cotton yarns. In 2006, it floated its IPO at a price of Rs.21/share. NSL manufactures 100% Cotton Yarns and Fabrics. Its manufacturing range includes open-end yarns, multifold openend yarns, ring s

Archies (Rs. 24.00) (Code: 532212) :- After a sharp correction, the share looks attractively priced at current levels. Some HNIs and value investors are keeping a close eye on the stock. The company is expected to do well in the upcoming festival season. The stock can deliver good returns in the short term. Oricon Enterprise (Rs. 56.00) (Code: 513121) :- The share of this multi division company, which has businesses in marine logistics, packaging and realty, has become circuit breakers. According to reports, Oricon Enterprise's subsidiary has received nod from BMC for developing residential project on 2 acre land in Mumbai. The company has invested Rs. 159 crores in the subsidiary for 100% equity, and it is presently valued at Rs. 400 crores. The company is also said to be forming a JV with a leading Mumbai-based developer. Godrej Properties (Rs. 323.00) (Code: 533150) :- This realty sector share is the favourite of HNIs and institutions. The company is expected to benefit

Kausambi Vanijya  (BSE Code : 538295) With a view to fool hapless small investors, a couple of  wily market operators are at again. This time they have  started a kite buying exercise to give a boost to the market  price of Kausambi Vanijya, a company which boasts of diversified business activity but mainly deals in stock mar kets. They aim as at least doubling the share price which is around Rs. 9 SMSs are being sent to hundreds of small  investors prompting them to buy as many shares as they  can buy from 1 lakh to 1 crore shares as these shares are  available, damn cheap. But the ‘advice’ of these experts is  ridiculous as even after 20 years, its revenues have not  gone beyond Rs. 4 crore and the net profit for the fiscal 2015 is hold your breath Rs. 1 lakh. It is also intriguing to  know that in the years ended March 2013, the company  has earned a net profit of Rs. 2 lakh on revenues of Rs.  4.14 crore. It is all the more intriguing that while the com- pany has ear

Fortis Healthcare (FORHEALT) is into healthcare services. It currently has a network of 11 hospitals primarily in North India and 16 satellite and heart command centers, including one heart command center in Afghanistan. These hospitals include multi-specialty hospitals as well as super-specialty centers providing tertiary and quaternary healthcare to patients in areas such as cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology and mother and child care. Established in 1996, Fortis Healthcare is one of the largest private healthcare companies in India promoted by Ranbaxy Laboratories.  Based in Delhi, FORHEALT is engaged in providing the latest in internationally recognized medical care to patients. It has built a tele-medicine network which connects each of its facilities in order to provide expert care to each patient. It also provides services covering ICU management, ER management, OPD management, radiology and pathology reporting. To boost its bus

VRL was founded in 1976 by DR. Vijay Sankeshwar in Gadag, a small town in North Karnataka with a single truck and a vision that was way ahead of its time. VRL gradually expanded its services to Bangalore, Hubli and Belgaum. From this humble beginning VRL has today grown into a nationally renowned logistics and transport company which is also currently the largest fleet owner of commercial vehicles in India with a fleet of 4077 Vehicles (Including 373 Passenger Transport Vehicles & 3704 Goods Transport Vehicles amongst others). VRL finds mention in the Limca Book of Record as the largest fleet owner of commercial vehicles in india in the Private Sector. Mr. Vijay Sankeshwar has now been joined by his son Mr. Anand Sankeshwar who brings in newer strategies to further drive the growth of the Company.  Over the years, VRL has pioneered in providing a safe and reliable delivery network in the field of parcel service. It has spread its operations to Courier Service, Priority Cargo &

Sumeet Industries  (BSE Code :  514211) A couple of market operators who are experts in kite flying  in stock markets have been trying to push up Sumeet Industries,  but their efforts have not yielded any positive result and the  share price with the face value of Rs. 10 is still quoted below par.  Of course, the company’s plans are not ordinary. With  sizeable investment in backward as well as forward integration  exercise, the company is emerging as an integrated producer  of pet chips, POY/FDY, texturised and multifilament polypro-  pylene yarns and now it is setting up a captive power plant at  a cost of Rs. 77 crore. However, credibility of the management  has suffered a severe setback after SEBI had caught the top  management for manipulating stock market a few years ago.

Cipla Ltd. (BSE Code: 500087) (CMP: Rs.654.95) (FV: Rs.2) (TGT: Rs.1500)  Cipla Ltd is a pharmaceutical company with business units focused on Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company offers APIs, formulations and veterinary products. As of 31 March 2015, Cipla offered services across five continents and in countries like India, South Africa, Europe and North America, among others. It offers over 1,000 products across 120 countries that treat cardiovascular diseases, children’s health, dermatology and cosmetology, diabetes, Human Immunodeficiency Virus/Acquired Immuno Deficiency syndrome (HIV/AIDS), infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women’s health. It also offers veterinary products in categories such as companion, equine, general care, livestock and poultry. Cipla’s UK arm has entered into an agreement to acquire two US-based companies, In